Geoffrey Gotto

Dr. Gotto is a Urologic Oncologist and Clinical Associate Professor in the Departments of Surgery and Oncology at the University of Calgary. He completed his undergraduate and residency training at the University of British Columbia and went on to complete his Fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center and his Masters of Public Health at Harvard. He specializes in the management of prostate, bladder, kidney, and testis cancers

Dr. Gotto is a national key opinion leader in the field of urologic oncology and currently sits on the Medical Advisory Board for Kidney Cancer Canada and Bladder Cancer Canada. He serves on the Scientific Program Committee for the Canadian Urological Association (CUA) and has been named a CUA Scholar. He has received numerous teaching awards from the Cumming School of Medicine at the University of Calgary and the Star Educator Award from the Department of Surgery.

Dr. Gotto is the founder and Medical Director of the Clinic for Advanced and Metastatic Prostate Cancer (CAMP) at Calgary’s Prostate Cancer Centre. He is also a Principal Investigator for a number of clinical trials in advanced prostate cancer. Recent peer-reviewed publications include co-authorship on the EMBARK clinical trial published in the New England Journal of Medicine.